BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 8134008)

  • 1. Atypical and malignant meningiomas: a clinicopathological review.
    Mahmood A; Caccamo DV; Tomecek FJ; Malik GM
    Neurosurgery; 1993 Dec; 33(6):955-63. PubMed ID: 8134008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: a study of 90 tumors.
    Abramovich CM; Prayson RA
    Hum Pathol; 1998 Dec; 29(12):1420-7. PubMed ID: 9865827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant and atypical meningiomas: a reappraisal of clinical, histological, and computed tomographic features.
    Alvarez F; Roda JM; Pérez Romero M; Morales C; Sarmiento MA; Blázquez MG
    Neurosurgery; 1987 May; 20(5):688-94. PubMed ID: 3601014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications.
    Perry A; Scheithauer BW; Stafford SL; Lohse CM; Wollan PC
    Cancer; 1999 May; 85(9):2046-56. PubMed ID: 10223247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Necrosis is a consistent factor to recurrence of meningiomas: should it be a stand-alone grading criterion for grade II meningioma?
    Góes P; Santos BFO; Suzuki FS; Salles D; Stávale JN; Cavalheiro S; de Paiva Neto MA
    J Neurooncol; 2018 Apr; 137(2):331-336. PubMed ID: 29270884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain Invasion in Meningiomas: Incidence and Correlations with Clinical Variables and Prognosis.
    Spille DC; Heß K; Sauerland C; Sanai N; Stummer W; Paulus W; Brokinkel B
    World Neurosurg; 2016 Sep; 93():346-54. PubMed ID: 27344043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meningioma grading: an analysis of histologic parameters.
    Perry A; Stafford SL; Scheithauer BW; Suman VJ; Lohse CM
    Am J Surg Pathol; 1997 Dec; 21(12):1455-65. PubMed ID: 9414189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
    Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
    Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma.
    Ho DM; Hsu CY; Ting LT; Chiang H
    Cancer; 2002 Mar; 94(5):1538-47. PubMed ID: 11920512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [X-ray computed tomographic aspects of malignant meningioma and meningeal hemangiopericytoma].
    Dufresne MC; Bédard F
    Can Assoc Radiol J; 1996 Aug; 47(4):279-87. PubMed ID: 8696997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computed tomography and angiography do not reliably discriminate malignant meningiomas from benign ones.
    Servo A; Porras M; Jääskeläinen J; Paetau A; Haltia M
    Neuroradiology; 1990; 32(2):94-7. PubMed ID: 2398947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and clinicopathological features of meningioma.
    Rohringer M; Sutherland GR; Louw DF; Sima AA
    J Neurosurg; 1989 Nov; 71(5 Pt 1):665-72. PubMed ID: 2809720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracranial meningiomas: analysis of recurrence after surgical treatment.
    Mahmood A; Qureshi NH; Malik GM
    Acta Neurochir (Wien); 1994; 126(2-4):53-8. PubMed ID: 8042555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of benign and aggressive intracranial meningiomas.
    Akeyson EW; McCutcheon IE
    Oncology (Williston Park); 1996 May; 10(5):747-56; discussion 756-9. PubMed ID: 8738830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [On diagnostics of malignant meningioma and invasive meningioma].
    Zhang S; Meng H; Gui Y; Chen L; Zhao T; Zhang X; Li G; Yang G
    Hua Xi Yi Ke Da Xue Xue Bao; 1996 Jun; 27(2):192-5. PubMed ID: 9389041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathological prognostic factors of recurrence following definitive therapy for atypical and malignant meningiomas.
    Kim D; Niemierko A; Hwang WL; Stemmer-Rachamimov AO; Curry WT; Barker FG; Martuza RL; Oh KS; Loeffler JS; Shih HA
    J Neurosurg; 2018 Apr; 128(4):1123-1132. PubMed ID: 28621619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy.
    Shino A; Nakasu S; Matsuda M; Handa J; Morikawa S; Inubushi T
    J Neurosurg; 1999 Dec; 91(6):928-34. PubMed ID: 10584837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A conceptual shift in the grading of meningiomas.
    Lohmann CM; Brat DJ
    Adv Anat Pathol; 2000 May; 7(3):153-7. PubMed ID: 10809221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical and malignant meningiomas: an outcome report of seventeen cases.
    Coke CC; Corn BW; Werner-Wasik M; Xie Y; Curran WJ
    J Neurooncol; 1998 Aug; 39(1):65-70. PubMed ID: 9760071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features.
    Yang SY; Park CK; Park SH; Kim DG; Chung YS; Jung HW
    J Neurol Neurosurg Psychiatry; 2008 May; 79(5):574-80. PubMed ID: 17766430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.